Orchestra BioMed Holdings, Inc. (OBIO)
Largest Insider Buys in Sector
OBIO Stock Price History Chart
OBIO Stock Performance
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of …
Insider Activity of Orchestra BioMed Holdings, Inc.
Over the last 12 months, insiders at Orchestra BioMed Holdings, Inc. have bought $151,785 and sold $225,567 worth of Orchestra BioMed Holdings, Inc. stock.
On average, over the past 5 years, insiders at Orchestra BioMed Holdings, Inc. have bought $151,785 and sold $225,567 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hochman David P (See Remarks) — $356,865. Little William Reed (See Remarks) — $28,000. Taylor Andrew Lawrence (Chief Financial Officer) — $4,830.
The last purchase of 1,000 shares for transaction amount of $4,830 was made by Taylor Andrew Lawrence (Chief Financial Officer) on 2024‑12‑19.
List of Insider Buy and Sell Transactions, Orchestra BioMed Holdings, Inc.
| 2024-12-19 | Chief Financial Officer | 1,000 0.0026% | $4.83 | $4,830 | +1.24% | |||
| 2024-12-18 | See Remarks | 5,000 0.0145% | $4.91 | $24,550 | -1.63% | |||
| 2024-09-25 | See Remarks | 7,500 0.0166% | $4.75 | $35,630 | +15.56% | |||
| 2024-09-24 | See Remarks | 2,500 0.0057% | $4.91 | $12,275 | +17.46% | |||
| 2024-09-10 | Sale | See Remarks | 6,904 0.0171% | $5.31 | $36,660 | -3.60% | ||
| 2024-09-10 | Sale | director | 1,800 0.0045% | $5.34 | $9,612 | -3.60% | ||
| 2024-09-09 | Sale | See Remarks | 6,804 0.0174% | $5.48 | $37,286 | -2.90% | ||
| 2024-09-09 | Sale | director | 1,800 0.0046% | $5.43 | $9,774 | -2.90% | ||
| 2024-09-06 | Sale | See Remarks | 6,819 0.018% | $5.65 | $38,527 | -4.10% | ||
| 2024-09-06 | Sale | director | 2,000 0.0053% | $5.64 | $11,280 | -4.10% | ||
| 2024-09-05 | Sale | See Remarks | 6,961 0.019% | $5.85 | $40,722 | -6.56% | ||
| 2024-09-04 | Sale | See Remarks | 6,837 0.0195% | $6.10 | $41,706 | -11.52% | ||
| 2024-08-14 | See Remarks | 2,500 0.0068% | $5.84 | $14,600 | +0.63% | |||
| 2024-06-25 | See Remarks | 1,000 0.0032% | $6.95 | $6,950 | -14.89% | |||
| 2024-05-30 | See Remarks | 4,000 0.0131% | $7.00 | $28,000 | -10.27% | |||
| 2024-05-17 | See Remarks | 3,000 0.0072% | $5.15 | $15,450 | +14.11% | |||
| 2024-05-16 | See Remarks | 2,000 0.0044% | $4.75 | $9,500 | +28.36% |